Puracyp, Inc.

Preclinical Development > Toxicology

 Puracyp offers screening service to assess activation of the nuclear receptors, AhR, PXR and CAR, using animal and human homologues.  Results enable clinical prediction of drug interactions involving induction of transporters and drug metabolizing enzymes.

Contact

Mark Dale CEO Phone: 760-929-9508 x106
www.puracyp.com
5900 Sea Lion Place #130 Carlsbad, CA 92010